{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:14:25Z","timestamp":1767827665186,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.vaccine.2017.10.090","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T14:45:39Z","timestamp":1510584339000},"page":"7107-7113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands"],"prefix":"10.1016","volume":"35","author":[{"given":"A.M.M.","family":"van Deursen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.M.","family":"Schurink-van't Klooster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"van de Kassteele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"van Gageldonk-Lafeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.C.J.L.","family":"Bruijning-Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.10.090_b0005","unstructured":"World Health Organisation. WHO pneumonia Fact sheet. Fact Sheet N\u00b0331 2014. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs331\/en\/> [accessed November 2, 2015]."},{"key":"10.1016\/j.vaccine.2017.10.090_b0010","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/INF.0b013e3182784b26","article-title":"The burden of childhood pneumonia in the developed world: a review of the literature","volume":"32","author":"Madhi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.10.090_b0015","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2017.10.090_b0020","doi-asserted-by":"crossref","first-page":"S296","DOI":"10.1093\/cid\/cir045","article-title":"Diagnostic tests for agents of community-acquired pneumonia","volume":"52","author":"Bartlett","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0025","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0030","doi-asserted-by":"crossref","first-page":"C26","DOI":"10.1016\/j.vaccine.2011.06.104","article-title":"Prevenar experience","volume":"29","author":"Arguedas","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.090_b0035","doi-asserted-by":"crossref","unstructured":"Schurink-van\u2019t Klooster TM, de Melker HM. The National Immunisation Programme in the Netherlands; 2015. doi:10.1017\/CBO9781107415324.004.","DOI":"10.1017\/CBO9781107415324.004"},{"key":"10.1016\/j.vaccine.2017.10.090_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0045","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0050","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.10.090_b0055","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/S2214-109X(16)30306-0","article-title":"Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis","volume":"5","author":"Shiri","year":"2017","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.10.090_b0060","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.3201\/eid2111.140780","article-title":"Invasive pneumococcal disease 3 years after introduction of 10-valent pneumococcal conjugate vaccine, the Netherlands","volume":"21","author":"Knol","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0075","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12879-016-1693-x","article-title":"Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children","volume":"16","author":"Nair","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"hospitalizations for pneumonia after a decade of pneumococcal vaccination","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/1471-2334-14-485","article-title":"A population-based study on the impact of hospitalization for pneumonia in different age groups","volume":"14","author":"Baldo","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0095","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1001\/jama.294.21.2712","article-title":"Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988\u20132002","volume":"294","author":"Fry","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.10.090_b0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid1405.071011","article-title":"Increasing hospital admissions for pneumonia, England","volume":"14","author":"Trotter","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0105","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2796.2006.01629.x","article-title":"Rising incidence and persistently high mortality of hospitalized pneumonia: a 10-year population-based study in Denmark","volume":"259","author":"Thomsen","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0110","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1017\/S0950268809002258","article-title":"Time trends in primary-care morbidity, hospitalization and mortality due to pneumonia","volume":"137","author":"van Gageldonk-Lafeber","year":"2009","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.10.090_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e31824de9f6","article-title":"The worldwide impact of the seven-valent pneumococcal conjugate vaccine","volume":"31","author":"Fitzwater","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.10.090_b0120","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States","volume":"2","author":"Simonsen","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2017.10.090_b0125","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trivac.2016.04.004","article-title":"A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)","volume":"5","author":"Patterson","year":"2016","journal-title":"Trials Vaccinol"},{"key":"10.1016\/j.vaccine.2017.10.090_b0130","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","article-title":"Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis","volume":"369","author":"Grijalva","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.10.090_b0135","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/archpedi.161.12.1162","article-title":"Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States","volume":"161","author":"Zhou","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0145","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: Randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.10.090_b0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/01.inf.0000232706.35674.2f","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia","volume":"25","author":"Hansen","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.10.090_b0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1097\/00006454-200209000-00005","article-title":"Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia","volume":"21","author":"Black","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.10.090_b0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJMoa1209165","article-title":"U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination (time series analysis)","volume":"369","author":"Griffin","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-2600(14)70032-3","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0170","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.rmed.2014.05.004","article-title":"Nationwide trends in pneumonia hospitalization rates and mortality, Denmark 1997\u20132011","volume":"108","author":"S\u00f8gaard","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0175","unstructured":"van Oosten M, de Greeff SC, Spanjaard LSL. Introduction of pneumococcal conjugate vaccine into the Dutch national immunisation programme. Eurosurveillance 2006;June 8:E060608.2."},{"key":"10.1016\/j.vaccine.2017.10.090_b0180","first-page":"950","article-title":"High vaccination coverage of the National Immunization Programme in the Netherlands","volume":"153","author":"van Lier","year":"2009","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2017.10.090_b0185","first-page":"1454","article-title":"Two pneumococcal vaccines: The 7-valent conjugate vaccine (prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (pneumo 23) for the elderly and specific groups at risk","volume":"151","author":"de Greeff","year":"2007","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.vaccine.2017.10.090_b0190","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3201\/eid1411.070467","article-title":"Antimicrobial drug use and resistance in Europe","volume":"14","author":"Van De Sande-Bruinsma","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1467-9868.2008.00700.x","article-title":"Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations","volume":"71","author":"Rue","year":"2009","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/j.vaccine.2017.10.090_b0200","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.vaccine.2009.01.127","article-title":"Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits","volume":"27","author":"Jansen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.090_b0205","doi-asserted-by":"crossref","first-page":"e112211","DOI":"10.1371\/journal.pone.0112211","article-title":"All-cause pneumonia hospitalizations in children","volume":"9","author":"Berglund","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.10.090_b0210","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"Rodenburg","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.10.090_b0215","unstructured":"RIVM; WHO. Rokers in de Europese Unie 2016. <https:\/\/www.volksgezondheidenzorg.info\/onderwerp\/roken\/regionaal-internationaal\/internationaal#node-percentage-rokers-de-europese-unie> (accessed November 14, 2016)."},{"key":"10.1016\/j.vaccine.2017.10.090_b0220","doi-asserted-by":"crossref","DOI":"10.4104\/pcrj.2013.00085","article-title":"General practitioners\u2019 contribution to the management of community acquired pneumonia in the Netherlands: a retrospective analysis of primary care, hospital, and national mortality databases with individual data linkage","volume":"22","author":"Snijders","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.vaccine.2017.10.090_b0225","first-page":"90","article-title":"SWAB\/NVALT (dutch working party on antibiotic policy and dutch association of chest physicians) guidelines on the management of community-acquired pneumonia in adults","volume":"70","author":"Wiersinga","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vaccine.2016.11.030","article-title":"Challenges to estimating vaccine impact using hospitalization data","volume":"35","author":"Schuck-Paim","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.10.090_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2016.11.012","article-title":"Epidemiology of viral pneumonia","volume":"38","author":"Jain","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0240","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1073\/pnas.1612833114","article-title":"Estimating the population-level impact of vaccines using synthetic controls","volume":"114","author":"Bruhn","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2017.10.090_b0245","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.10.090_b0250","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/erv.10.163","article-title":"Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination","volume":"10","author":"Rozenbaum","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.10.090_b0255","unstructured":"Sloot R, Hooiveld M, Veen PMH, Korevaar J. Factsheet vaccine coverage dutch national influenza prevention program 2014 Main results The findings are based on data from 188 general vaccination, defined by age (60 years or older) and Compared to previous years, the vaccine coverage in the target; 2015. p. 2013\u20134."},{"key":"10.1016\/j.vaccine.2017.10.090_b0260","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jclinepi.2006.10.018","article-title":"International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia","volume":"60","author":"van de Garde","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2017.10.090_b0265","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jama.2012.384","article-title":"Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003\u20132009","volume":"307","author":"Lindenauer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.10.090_b0270","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.10.090_b0275","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2217\/fmb.12.29","article-title":"Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship?","volume":"7","author":"Short","year":"2012","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2017.10.090_b0280","first-page":"311","article-title":"Q-koorts in Nederland van 2007 tot heden","volume":"21","author":"Oomen","year":"2010","journal-title":"Infect Bull"},{"key":"10.1016\/j.vaccine.2017.10.090_b0285","first-page":"328","article-title":"Onderzoek in het kort Q-koorts onderzoek in Nederland : resultaten tot nu toe","volume":"22","author":"Van","year":"2011","journal-title":"Infect Bull"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17314986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T04:50:45Z","timestamp":1659847845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17314986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":57,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0264410X17314986"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.090","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of infant pneumococcal conjugate vaccination on community acquired pneumonia hospitalization in all ages in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}